ClinicalTrials.Veeva

Menu

Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)

L

LifeWatch Services

Status

Completed

Conditions

Desaturation of Blood

Treatments

Device: Vital Signs Patch (VSP)

Study type

Interventional

Funder types

Industry

Identifiers

NCT01899911
CD-0024

Details and patient eligibility

About

A clinical study designed to determine the accuracy of the peripheral capillary oxygen saturation (SpO2) function of the Vital Signs Patch (VSP) device for measuring blood saturation level.

Full description

The clinical study protocol was designed for determining the accuracy of the SpO2 function of the Vital Signs Patch device for measuring blood oxygen saturation level, according to the guidelines for "evaluating and documenting SpO2 accuracy in human subjects" as set out in Annex EE of ISO 80601-2-61. Section 4.

Enrollment

12 patients

Sex

All

Ages

23 to 33 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages 23 to 33.
  • Skin tone varied from light to dark.

Exclusion criteria

  • Smokers
  • Anemic

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Vital Signs Patch (VSP)
Experimental group
Description:
Infrared and Red absorbance measurement on chest
Treatment:
Device: Vital Signs Patch (VSP)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems